Published in AIDS Res Hum Retroviruses on January 01, 2008
Intima-Media Thickness in the Carotid and Femoral Arteries for Detection of Arteriosclerosis in Human Immunodeficiency Virus-Positive Individuals. Arq Bras Cardiol (2017) 0.75
Coronary artery endothelial dysfunction is present in HIV positive individuals without significant coronary artery disease. AIDS (2017) 0.75
HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress. PLoS One (2017) 0.75
Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1. Ann Intern Med (2011) 4.21
Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. Ann Intern Med (2014) 3.48
Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysis. Clin Infect Dis (2012) 2.36
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis (2009) 2.05
AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics. HIV Clin Trials (2008) 1.99
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr (2002) 1.98
Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection. AIDS (2010) 1.54
Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. PLoS Pathog (2009) 1.53
A novel diagnostic target in the hepatitis C virus genome. PLoS Med (2009) 1.52
Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. J Clin Endocrinol Metab (2006) 1.49
Use of protein antigens for early serological diagnosis of leprosy. Clin Vaccine Immunol (2007) 1.45
Whole-blood interleukin-18 level during early HIV-1 infection is associated with reduced CXCR4 coreceptor expression and interferon- gamma levels. J Infect Dis (2007) 1.42
Paragonimiasis: first case reported in Brazil. Braz J Infect Dis (2007) 1.41
The use of pooled viral load testing to identify antiretroviral treatment failure. AIDS (2009) 1.37
Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil. J Clin Microbiol (2007) 1.37
No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT. Clin Infect Dis (2011) 1.32
Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS Clinical Trials Group study. J Infect Dis (2006) 1.31
Primary antiretroviral drug resistance among HIV type 1-infected individuals in Brazil. AIDS Res Hum Retroviruses (2009) 1.26
Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapy. J Acquir Immune Defic Syndr (2007) 1.16
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186. J Acquir Immune Defic Syndr (2008) 1.15
Severe and Norwegian scabies are strongly associated with retroviral (HIV-1/HTLV-1) infection in Bahia, Brazil. AIDS (2002) 1.14
Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs. J Acquir Immune Defic Syndr (2014) 1.14
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation? AIDS Res Ther (2010) 1.13
Immunotherapy for drug-refractory mucosal leishmaniasis. J Infect Dis (2006) 1.12
Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study. Clin Infect Dis (2013) 1.11
Extensive geographical mixing of 2009 human H1N1 influenza A virus in a single university community. J Virol (2011) 1.11
100% adherence study: educational workshops vs. video sessions to improve adherence among ART-naïve patients in Salvador, Brazil. AIDS Behav (2008) 1.08
Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis. Oncology (2011) 0.99
Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE. Vaccine (2010) 0.98
Strengthening research capacity through the medical education partnership initiative: the Mozambique experience. Hum Resour Health (2013) 0.98
The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy. AIDS (2013) 0.97
Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs. Vet Parasitol (2008) 0.97
Efficacy and safety of Efavirenz in HIV patients on Rifampin for tuberculosis. Braz J Infect Dis (2004) 0.95
Post-kala-azar dermal leishmaniasis associated with AIDS. Braz J Infect Dis (2003) 0.93
Association between skin parasitism and a granulomatous inflammatory pattern in canine visceral leishmaniosis. Parasitol Res (2003) 0.93
Risk of tuberculosis among household contacts in Salvador, Bahia. Braz J Infect Dis (2005) 0.93
Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapy. Clin Vaccine Immunol (2008) 0.91
Performance evaluation of the MBio Diagnostics point-of-care CD4 counter. J Immunol Methods (2012) 0.90
Post-kala-azar dermal leishmaniasis associated with AIDS. Braz J Infect Dis (2003) 0.90
Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials study. J Acquir Immune Defic Syndr (2010) 0.88
Vicriviroc plus optimized background therapy for treatment-experienced subjects with CCR5 HIV-1 infection: final results of two randomized phase III trials. J Infect (2012) 0.87
Multicenter evaluation of SonoVue for improved endocardial border delineation. Echocardiography (2002) 0.87
Cross-sectional study to evaluate factors associated with adherence to antiretroviral therapy by Brazilian HIV-infected patients. AIDS Res Hum Retroviruses (2006) 0.87
An adherence trilogy is essential for long-term HAART success. Braz J Infect Dis (2003) 0.87
Tuberculosis due to Mycobacterium bovis in patients coinfected with human immunodeficiency virus. Clin Infect Dis (2010) 0.85
The effect of the menstrual cycle on glucose control in women with type 1 diabetes evaluated using a continuous glucose monitoring system. Diabetes Care (2013) 0.85
Assessment of cardiovascular risk factors in a rural community in the Brazilian state of Bahia. Arq Bras Cardiol (2003) 0.84
Characteristics of co-infections by HCV and HBV among Brazilian patients infected by HIV-1 and/or HTLV-1. Braz J Infect Dis (2013) 0.84
TB-IRIS after initiation of antiretroviral therapy is associated with expansion of preexistent Th1 responses against Mycobacterium tuberculosis antigens. J Acquir Immune Defic Syndr (2013) 0.83
Evaluation of hemodynamic variations during anesthetic induction in treated hypertensive patients. Rev Bras Anestesiol (2009) 0.82
Evaluation of blood stream infections by Candida in three tertiary hospitals in Salvador, Brazil: a case-control study. Braz J Infect Dis (2006) 0.82
Domestic swine in a visceral leishmaniasis endemic area produce antibodies against multiple Leishmania infantum antigens but apparently resist to L. infantum infection. Acta Trop (2006) 0.82
Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy. AIDS (2015) 0.81
Barriers to prevention of HIV type 1 mother-to-child-transmission in Bahia, Brazil. AIDS Res Hum Retroviruses (2011) 0.81
Nosocomial gastroenteritis in children with and without rotavirus infection. Pediatr Infect Dis J (2009) 0.81
Coinfection with HIV and human T lymphotropic virus type 1: what is the real impact on HIV disease? Clin Infect Dis (2005) 0.81
Innovative strategies for transforming internal medicine residency training in resource-limited settings: the Mozambique experience. Acad Med (2014) 0.81
Prevalence of sexually transmitted infections among HIV-infected women in Brazil. Braz J Infect Dis (2012) 0.80
Use of Rhu-GM-CSF in pulmonary tuberculosis patients: results of a randomized clinical trial. Braz J Infect Dis (2003) 0.80
Lack of effect of motivation on the adherence of HIV-positive/AIDS patients to antiretroviral treatment. Braz J Infect Dis (2006) 0.80
Syphilis and HIV-1 among parturient women in Salvador, Brazil: low prevalence of syphilis and high rate of loss to follow-up in HIV-infected women. Braz J Infect Dis (2013) 0.79
Obesity and postprandial lipemia in adolescents: risk factors for cardiovascular disease. Endocrinol Nutr (2011) 0.78
Coinfection by HIV-1 and human lymphotropic virus type 1 in Brazilian children is strongly associated with a shorter survival time. J Acquir Immune Defic Syndr (2011) 0.78
Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons. AIDS (2016) 0.77
C-reactive protein is not correlated with endothelial dysfunction in overweight and obese women. J Clin Med Res (2013) 0.77
Prevalence and factors associated with dry skin in HIV infection: the FRAM study. AIDS (2007) 0.77
AIDS related malignancies in Brazil. Curr Opin Oncol (2007) 0.77
Drug-resistant virus has reduced ability to induce immune activation. J Acquir Immune Defic Syndr (2012) 0.76
The importance of the doctor-patient relationship in adherence to HIV/AIDS treatment: a case report. Braz J Infect Dis (2005) 0.76
Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS. J Acquir Immune Defic Syndr (2014) 0.76
Safety and immunovirologic outcomes with maraviroc combination regimens in patients with a history of past treatment failures and virologic resistance in Brazil: an open-label, multicenter phase 3b study. AIDS Res Hum Retroviruses (2013) 0.76
Treating tuberculosis in AIDS patients: when to start and how long to keep giving drugs? AIDS (2002) 0.75
Ebstein's anomaly with left ventricular noncompaction and bicuspid aortic valve. J Am Coll Cardiol (2010) 0.75
Choosing between a NOAC or a vitamin K antagonist: an approach based on risk stratification. Eur Heart J (2017) 0.75
Risk factors for nosocomial rotavirus infection in a paediatric hospital: the potential role for rotavirus vaccine use. Vaccine (2008) 0.75
Clinical and ultramicroscopic myocardial randomized study of beating versus arrested heart for mitral surgery. Rev Bras Cir Cardiovasc (2013) 0.75
Brazilian Society of Infectious Diseases: 25 years! Braz J Infect Dis (2005) 0.75
Comparison of dobutamine stress echocardiography with and without real-time perfusion imaging for detection of coronary artery disease. Am J Cardiol (2005) 0.75
Effect of microbubble fragility on transit rate measurement by contrast echography. Ultrasound Med Biol (2003) 0.75
Visualization of risk-area myocardium as a high-intensity, hyperenhanced "hot spot" by myocardial contrast echocardiography following coronary reperfusion: quantitative analysis. J Am Coll Cardiol (2003) 0.75
Infection By Htlv-1 Is Associated With High Levels Of Pro-Inflammatory Cytokines, In Hiv-Hcv Coinfected Patients. J Acquir Immune Defic Syndr (2017) 0.75
Survival Estimates and Mortality Risk Factors in a Cohort of HIV Vertically Infected Individuals in Salvador, Brazil. Pediatr Infect Dis J (2016) 0.75